Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Proteomic and Bioinformatic Analysis of Trypanosoma cruzi Chemotherapy and Potential Drug Targets: New Pieces for an Old Puzzle

Volume:15   Issue:3
Pp: 255-271
Rubem Figueiredo Sadok Menna-Barreto, Kele Teixeira Belloze, Jonas Perales and Floriano Paes Silva-Jr
DOI: 10.2174/13894501113146660218

Pannexin Channels: The Emerging Therapeutic Targets

Volume:15   Issue:3
Pp: 272-280
Misbahuddin Mohammad and Hamed Said Habib
DOI: 10.2174/13894501113146660217

Microneedle-Based Drug Delivery Systems for Transdermal Route

Volume:15   Issue:3
Pp: 281-291
Maria Bernadete Riemma Pierre and Fabia Cristina Rossetti
DOI: 10.2174/13894501113146660232

Lipid Nanocarriers and Molecular Targets for Malaria Chemotherapy

Volume:15   Issue:3
Pp: 292-312
Kunal Jain, Sumeet Sood and Kuppusamy Gowthamarajan
DOI: 10.2174/13894501113146660235

Current Therapeutic Advances in Patients and Experimental Models of Huntington's Disease

Volume:15   Issue:3
Pp: 313-334
Ana C. Brett, Tatiana R. Rosenstock and A. Cristina Rego
DOI: 10.2174/1389450114666131124140704

COX-2 Signaling and Cancer: New Players in Old Arena

Volume:15   Issue:3
Pp: 347-359
Shashank Misra and Kulbhushan Sharma
DOI: 10.2174/1389450115666140127102915